help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 8, 2004
Molecular Endocrinology, doi:10.1210/me.2003-0260
Molecular Endocrinology Vol. 0, No. 2004 200302601-
doi:10.1210/me.2003-0260
Copyright © 2004 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
18/4/863    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Villa, A.
Right arrow Articles by Pascual, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Villa, A.
Right arrow Articles by Pascual, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LIOTHYRONINE

Submitted on July 2, 2003
Accepted on December 31, 2003

A response unit in the first exon of the APP gene containing TR and Sp1 binding sites mediates negative regulation by T3

Ana Villa, Jorge Santiago, Borja Belandia, and Angel Pascual*

Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

* To whom correspondence should be addressed. E-mail: apascual{at}biomed.iib.uam.es.

Thyroid hormones repress expression of APP ({beta}-amyloid precursor protein) in cultured cells of neuronal origin. The effect involves binding to the nuclear thyroid hormone receptor (TR) and is mediated by DNA sequences located within the first exon of the gene. These sequences contain a thyroid hormone receptor binding element (TRE) which is necessary but not sufficient to mediate the inhibitory effect of the thyroid hormone triiodothyronine (T3). In this report, we show that repression by T3 is mediated by a response unit composed by the TRE and 5'-flanking sequences that bind Sp1 and mediate stimulation by this transcription factor. In that unit binding sites for TR and Sp1 overlap and a complex mechanism appears to account for the TR-mediated regulation of APP. Unliganded TR does not bind to DNA, and allows Sp1 bind to DNA and stimulate APP basal expression. Binding of ligand T3, which increases affinity of TR by DNA, precludes binding of Sp1 to DNA and decreases the Sp1-dependent expression of APP.


Key words: Gene regulation • APP ({beta}-amyloid precursor protein) promoter • neuroblastoma cells • TR (Thyroid hormone receptor) • TRE (Thyroid hormone response element) • Sp1

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα  |  TRβ
Ligands:   Thyroid hormone






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society